Evidence map›Paper›PMID 42260285›Full record

ReviewZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2026

[

Kai Wang, Siqi Li, Yongming Zhang, Minxin Guan

Abstract readReviewEnglish Abstract
In one paragraph

Review in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kai WangInstitute of Genetics, Zhejiang University, Hangzhou 310058, China. 22318053@zju.edu.cn.
Siqi LiInstitute of Genetics, Zhejiang University, Hangzhou 310058, China.
Yongming ZhangThe Fourth Affiliated Hospital, Zhejiang University School of Medicine, Yiwu 322000, Zhejiang Province, China.
Minxin GuanInstitute of Genetics, Zhejiang University, Hangzhou 310058, China. gminxin88@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Leber hereditary optic neuropathy (LHON) is a typical mitochondrial genetic optic neuropathy predominantly affecting retinal ganglion cells and leading to irreversible visual damage. Although a single primary mitochondrial DNA (mtDNA) mutation provides the basis for the disease, it cannot fully explain its incomplete penetrance, male predominance, and clinical heterogeneity. Based on familial genetic analysis and functional studies, this review summarizes the "triple-hit" pathogenic mechanism of LHON. The first hit consists of primary mtDNA mutations, such as m.11778G>A, m.14484T>C, and m.3460G>A, which primarily impair respiratory chain complex Ⅰ function and weaken mitochondrial energy metabolism. The second hit involves mtDNA modifier variants, mtDNA haplogroup backgrounds, and nuclear modifier gene variants, which lower the threshold for disease onset and affect the penetrance in primary mtDNA mutation carriers. The third hit consists of non-genetic triggers, including exogenous exposures (such as smoking, alcohol consumption, and exposure to mitochondrial-toxic drugs) and endogenous physiological abnormalities (such as sex hormone-related differences in mitochondrial protection), which further weaken mitochondrial compensatory capacity and ultimately precipitate retinal ganglion cell damage. This review provides an integrated framework for understanding the pathogenic mechanism of LHON, aiming to serve as a reference for the screening of high-risk individuals, genetic counseling, risk prediction, and mechanism-driven clinical research of LHON.

Indexed as

DNA, MitochondrialMutationOptic Atrophy, Hereditary, LeberHumansDNA, MitochondrialLeber hereditary optic neuropathyMaternal inheritanceMitochondrial disorderMitochondrial DNAReview

Identifiers

PMID42260285
PMCPMC13652680

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.